Surface Oncology
Why Robinhood?
You can watch SURF and buy or sell other stocks, ETFs, and their options commission-free!About SURF
Surface Oncology, Inc. operates as a clinical-stage immuno-oncology company, which engages in the provision of biological pathways critical to the immunosuppressive tumor microenvironment for the development of next-generation cancer therapies. The firm’s pipeline includes wholly-owned lead programs targeting CD39 (SRF617) and IL-27 (SRF388), as well as a preclinical program focused on depleting tumor regulatory T cells via targeting CCR8 (SRF114).
SURF Key Statistics
Stock Snapshot
Surface Oncology(SURF) stock is priced at $1.07, giving the company a market capitalization of 65.08M. It carries a P/E multiple of -0.70.
During the trading day, Surface Oncology(SURF) stock saw an opening price of —, a peak of —, and a bottom of —.
Trading volume for Surface Oncology(SURF) stock has reached 0, versus its average volume of 292.98K.
The stock's 52-week range extends from a low of $0.56 to a high of $1.43.
The stock's 52-week range extends from a low of $0.56 to a high of $1.43.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.